Current melanoma treatments: where do we stand?
A Moreira, L Heinzerling, N Bhardwaj, P Friedlander - Cancers, 2021 - mdpi.com
Simple Summary In this manuscript, we discuss recent updates on melanoma-related
clinical trial data. We explore diverse topics, including new therapeutic agents and novel …
clinical trial data. We explore diverse topics, including new therapeutic agents and novel …
[HTML][HTML] Novel adjuvant options for cutaneous melanoma
Background Patients with resected stage III and IV melanoma have a high risk of recurrence.
As the outcomes for patients with metastatic disease have improved dramatically over the …
As the outcomes for patients with metastatic disease have improved dramatically over the …
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysis
Background Adjuvant targeted therapy (TT) improves relapse free survival in patients with
resected BRAF mutant stage III melanoma. The outcomes and optimal management of …
resected BRAF mutant stage III melanoma. The outcomes and optimal management of …
[HTML][HTML] How we treat locoregional melanoma
T Troiani, V De Falco, S Napolitano, C Trojaniello… - ESMO open, 2021 - Elsevier
Highlights•Melanoma is the deadliest of skin cancers, although most cases are resectable at
diagnosis.•Use of targeted therapies and immunotherapies as adjuvant treatment …
diagnosis.•Use of targeted therapies and immunotherapies as adjuvant treatment …
Applying adjuvant therapy for melanoma into clinical practice
T Krishnan, AM Menzies… - Expert Review of …, 2021 - Taylor & Francis
Patients with melanoma who have regional nodal or intransit involvement at diagnosis
(stage III) are at a high risk for recurrence, with the 5-year survival ranging from 93% for IIIA …
(stage III) are at a high risk for recurrence, with the 5-year survival ranging from 93% for IIIA …
[HTML][HTML] Current landscape and open questions on adjuvant therapies in melanoma
V De Falco, S Napolitano, LP Guerrera… - … Practical & Conceptual, 2021 - ncbi.nlm.nih.gov
Melanoma is a form of skin cancer that is frequently diagnosed at early stages. In most
cases, surgical resection is curative. In case of thicker melanomas (> pT1b) without clinical …
cases, surgical resection is curative. In case of thicker melanomas (> pT1b) without clinical …
Current Melanoma Treatments: Where Do We Stand? Cancers. 2021; 13: 221
A Moreira, L Heinzerling, N Bhardwaj, P Friedlander - 2021 - search.proquest.com
Groundbreaking research in immunology and cancer biology in the last few decades has led
to the discovery and development of novel therapeutics, such as immune checkpoint …
to the discovery and development of novel therapeutics, such as immune checkpoint …